MLchartDataset catalogue

KDM4 inhibitor TACH101

Term · Oncology and biomedicine · MLC-T-ONC-014636

An orally bioavailable, small-molecule, pan inhibitor of histone lysine (K) demethylase 4 (KDM4), with potential antineoplastic activity. Upon oral administration, KDM4 inhibitor TACH101 specifically targets, binds to and inhibits the catalytic activity of all members of the KDM4 family of proteins. This may prevent KDM4-mediated signaling, epigenetic dysregulation and inhibit the proliferation of tumor cells. The KDM4 family of histone demethylases is frequently upregulated in a variety of cancers and plays an important role in nuclear functions including the regulation of transcription, cell cycle, and DNA replication and repair.

Table 1. Record
IdentifierMLC-T-ONC-014636
FieldOncology and biomedicine
Synonymshistone lysine demethylase 4 inhibitor TACH101
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014636",
  "term": "KDM4 inhibitor TACH101",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable, small-molecule, pan inhibitor of histone lysine (K) demethylase 4 (KDM4), with potential antineoplastic activity. Upon oral administration, KDM4 inhibitor TACH101 specifically targets, binds to and inhibits the catalytic activity of all members of the KDM4 family of proteins. This may prevent KDM4-mediated signaling, epigenetic dysregulation and inhibit the proliferation of tumor cells. The KDM4 family of histone demethylases is frequently upregulated in a variety of cancers and plays an important role in nuclear functions including the regulation of transcription, cell cycle, and DNA replication and repair.",
  "synonyms": [
    "histone lysine demethylase 4 inhibitor TACH101"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/kdm4-inhibitor-tach101/"
}

Record 9,740 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.